ONCODES.PREC.MED. EO-34 (ZR8) — Defensive Interval Ratio
ONCODES.PREC.MED. EO-34 (ZR8) has a Defensive Interval Ratio of 553 days as of December 2024. Defensive assets of €5.46 Million (cash €-, short-term investments €4.84 Million, receivables €624.20K) cover 553 days of daily cash needs of €9.88K/day. Check ZR8 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ONCODES.PREC.MED. EO-34 Defensive Interval Ratio (2021–2024)
This chart shows how ONCODES.PREC.MED. EO-34's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 553 days, meaning defensive assets of €5.46 Million can fund 553 days of operations without new revenue. Also explore net asset momentum of ONCODES.PREC.MED. EO-34 to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for ONCODES.PREC.MED. EO-34 (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for ONCODES.PREC.MED. EO-34 from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ONCODES.PREC.MED. EO-34 (ZR8) market capitalisation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 553 days | €5.46 Million | €9.88K/day | €- | €4.84 Million | ▼ -430 days |
| 2023 | 983 days | €11.08 Million | €11.27K/day | €- | €10.01 Million | ▲ +927 days |
| 2022 | 56 days | €606.50K | €10.86K/day | €- | €125.00K | ▼ -51 days |
| 2021 | 107 days | €354.85K | €3.31K/day | €- | €- | — |